Peptide-based inhibitors of tau aggregation as a potential therapeutic for Alzheimer's disease
Tauopathies are a group of neurodegenerative diseases characterized by the deposition of misfolded and aggregated Tau protein in patients’ brains. Alzheimer's disease (AD), the most common tauopathy and leading cause of dementia, affects over 55 million people worldwide, with prevalence projected to double every two ye...